Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 21;9(5):269.
doi: 10.3390/antibiotics9050269.

The Israeli Phage Bank (IPB)

Ortal Yerushalmy  1 , Leron Khalifa  1 , Naama Gold  1 , Chani Rakov  1 , Sivan Alkalay-Oren  1 , Karen Adler  1 , Shira Ben-Porat  1 , Reut Kraitman  1 , Niv Gronovich  2 , Kerem Shulamit Ginat  2 , Mohanad Abdalrhman  3 , Shunit Coppenhagen-Glazer  1 , Ran Nir-Paz  3 , Ronen Hazan  1
Affiliations

The Israeli Phage Bank (IPB)

Ortal Yerushalmy et al. Antibiotics (Basel). .

Abstract

A key element in phage therapy is the establishment of large phage collections, termed herein "banks", where many well-characterized phages, ready to be used in the clinic, are stored. These phage banks serve for both research and clinical purposes. Phage banks are also a key element in clinical phage microbiology, the prior treatment matching of phages and antibiotics to specific bacterial targets. A worldwide network of phage banks can promote a phage-based solution for any isolated bacteria. Herein, we describe the Israeli Phage Bank (IPB) established in the Hebrew University, Jerusalem, which currently has over 300 phages matching 16 bacteria, mainly pathogens. The phage bank is constantly isolating new phages and developing methods for phage isolation and characterization. The information on the phages and bacteria stored in the bank is available online.

Keywords: IBP; bacteriophage; phage bank; phage database; phage therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The future phage therapy center’s mode of operation.
See this image and copyright information in PMC

References

    1. Paule A., Frezza D., Edeas M. Microbiota and Phage Therapy: Future Challenges in Medicine. Med. Sci. 2018;6:86. doi: 10.3390/medsci6040086. - DOI - PMC - PubMed
    1. Hanlon G.W. Bacteriophages: An Appraisal of Their Role in the Treatment of Bacterial Infections. Int. J. Antimicrob. Agents. 2007;30:118–128. doi: 10.1016/j.ijantimicag.2007.04.006. - DOI - PubMed
    1. Lin D.M., Koskella B., Lin H.C. Phage therapy: An Alternative to Antibiotics in The Age of Multi-Drug Resistance. World J. Gastrointest Pharmacol. Ther. 2017;8:162. doi: 10.4292/wjgpt.v8.i3.162. - DOI - PMC - PubMed
    1. Jault P., Leclerc T., Jennes S., Pirnay J.P., Que Y.A., Resch G., Rousseau A.F., Ravat F., Carsin H., Le Floch R., et al. Efficacy and Tolerability of a Cocktail of Bacteriophages to Treat Burn Wounds Infected by Pseudomonas Aeruginosa (Phagoburn): A Randomised, Controlled, Double-Blind Phase 1/2 Trial. Lancet Infect. Dis. 2019;19:35–45. doi: 10.1016/S1473-3099(18)30482-1. - DOI - PubMed
    1. Sarker S.A., Sultana S., Reuteler G., Moine D., Descombes P., Charton F., Bourdin G., McCallin S., Ngom-Bru C., Neville T., et al. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine. 2016;4:124–137. doi: 10.1016/j.ebiom.2015.12.023. - DOI - PMC - PubMed

LinkOut - more resources